In this episode, we delve into a recent study on Ventilator-associated pneumonia, a common hospital-acquired infection worldwide. We explore the innovative approach of using inhaled antibiotic therapy, specifically a 3-day course of inhaled amikacin, to potentially reduce the incidence of this disease. Original article here.

ABOUT THE STATE OF HEALTH

The State of Health helps you understand the most important news and research in healthcare and medicine. For more visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠stateofhealth.care⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

FOLLOW US

Exploring Thalidomide's potential in managing recurrent bleeding from small-intestinal angiodysplasia. Original article here.

ABOUT THE STATE OF HEALTH

The State of Health helps you understand the most important news and research in healthcare and medicine. For more visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠stateofhealth.care⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

FOLLOW US

Explore a significant study on treatment-resistant major depressive disorder in this episode. We examine the potential benefits of esketamine nasal spray versus extended-release quetiapine, both used in combination with an SSRI or SNRI. The findings could change the future approach to treating this prevalent condition. Original article here.

ABOUT THE STATE OF HEALTH

The State of Health helps you understand the most important news and research in healthcare and medicine. For more visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠stateofhealth.care⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

FOLLOW US

Explore the profound impact of controllable risk factors on global cardiovascular health and mortality. This episode sheds light on how effective management of these factors could significantly reduce cardiovascular diseases worldwide. Original article here.

ABOUT THE STATE OF HEALTH

The State of Health helps you understand the most important news and research in healthcare and medicine. For more visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠stateofhealth.care⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

FOLLOW US

Recent clinical trials have investigated the effectiveness and safety of psilocybin, a psychedelic substance, as a potential treatment for Major Depressive Disorder, underscoring its potential to revolutionize future mental health treatments. Original Article here.

ABOUT THE STATE OF HEALTH

The State of Health helps you understand the most important news and research in healthcare and medicine. For more visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠stateofhealth.care⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

FOLLOW US

We discuss a trailblazing trial examining the use of hybrid closed-loop therapy in pregnancies complicated by Type 1 Diabetes. Learn how this novel approach can improve glucose control and potentially transform diabetic pregnancy management. Original article here.

ABOUT THE STATE OF HEALTH

The State of Health helps you understand the most important news and research in healthcare and medicine. For more visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠stateofhealth.care⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

FOLLOW US

A comparison of glucose control methods in ICU patients found no significant difference in ICU stay length or mortality rates. Tight glucose control resulted in slightly higher hypoglycemia but less severe kidney injury and liver dysfunction. Original article here.

ABOUT THE STATE OF HEALTH

The State of Health helps you understand the most important news and research in healthcare and medicine. For more visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠stateofhealth.care⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

FOLLOW US

We dive into a recent trial examining the effectiveness of the antibiotic ceftobiprole against complicated Staphylococcus aureus bacteremia, including methicillin-resistant strains. Original article here.

ABOUT THE STATE OF HEALTH

The State of Health helps you understand the most important news and research in healthcare and medicine. For more visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠stateofhealth.care⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

FOLLOW US

Examining the recent shift in mammography screening guidelines, this podcast delves into the evidence and implications of lowering the recommended age from 50 to 40. We'll analyze the statistical models supporting this change, discuss the potential harms and benefits, and explore its impact on disparities in breast cancer mortality. Original article here.

ABOUT THE STATE OF HEALTH

The State of Health helps you understand the most important news and research in healthcare and medicine. For more visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠stateofhealth.care⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

FOLLOW US

We explore the efficacy of the non-vitamin K antagonist edoxaban as an anticoagulant in patients with atrial high-rate episodes (AHREs) from the perspective of the NOAH-AFNET 6 trial. We discuss the intriguing results and what they might mean for current clinical practice in stroke prevention. Original article here.

ABOUT THE STATE OF HEALTH

The State of Health helps you understand the most important news and research in healthcare and medicine. For more visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠stateofhealth.care⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

FOLLOW US